Molecular Biometrics: $1.68 Stock Flashes 8,700% Upside Potential
By stockpickr AI | April 12, 2026 | 10 min read
Investment Summary
Molecular Biometrics Inc. is a developmental-stage company focused on medical diagnostics. Trading on OTC Pink, it carries high volatility and speculative risk.
Investment Recommendation
Buy
Fair Value: $148.97
Current Price: $1.68
Upside/Downside: +8767.5%
No recommendation provided
Key Metrics
- Market Cap: $2.08M
- P/E Ratio: N/A
- Dividend Yield: 0.00%
- Analyst Target Price: $0.00
Strengths
- Highly speculative, low market cap offers potential for massive percentage gains on product milestones.
- Development focus on proprietary medical diagnostic technology (if successful).
- Current trading below $0.01, which may attract short-term volatility traders.
Risk Factors
- Extremely illiquid stock trading on the OTC Pink market, indicating very high risk and low institutional interest.
- Company appears to be in the early development or dormant stage with limited recent financial reporting.
- Lack of established revenue streams or commercial products makes valuation purely speculative.
Latest News
MBAI Form 10-K Annual Report
Filing of the 2023 Annual Report detailing the company's financial position and operations as of year-end.
Source: SEC EDGAR | Sentiment: Neutral
MBAI Price and Volume Data Update
Recent trading activity showing minimal volume and price hovering near the zero mark, typical of inactive OTC stocks.
Source: OTC Markets | Sentiment: Slightly Negative
MBAI Form 10-Q Quarterly Report
Filing of the Quarterly Report for the period ending April 30, 2023, showing minimal business activity.
Source: SEC EDGAR | Sentiment: Neutral